Physician profile
James N Long
NPI 1598795957
$478.86
in general payments reported to CMS, 2019-2025
16 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.08 · 2020: $107 · 2021: $84.57 · 2022: $64.96 · 2023: $60.93 · 2024: $21.60 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $111.01 | 2022-2023 | Xeomin |
| Kerecis Limited | $48.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Fidia Pharma USA INC. | $43.45 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $43.17 | 2024-2025 | |
| Heron Therapeutics, INC. | $43.14 | 2025 | Zynrelef |
| Pacira Therapeutics, INC. | $30.24 | 2020 | |
| Sientra, INC. | $18.77 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $18.71 | 2021 | |
| Convatec INC. | $17.75 | 2020 | |
| Acera Surgical, INC. | $16.79 | 2021 | |
| Ethicon US, LLC | $15.88 | 2021 | |
| Edwards Lifesciences Corporation | $15.42 | 2020 | |
| Acacia Pharma INC | $14.88 | 2022 | |
| Medline Industries LP | $14.20 | 2021 | |
| Kci USA, INC. | $13.91 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.